Analgesic and antiinflammatory drug prescriptions and number of radiograms predict antidepressant treatment. Study of reimbursement data from the Provence health insurance fund;Les prescriptions d'antalgiques, d'anti-inflammatoires ou le nombre d'actes radiologiques sont des facteurs prédictifs d'un traitement par antidépresseur. Une étude des données de remboursements de la Caisse médicale régionale de Provence

Presse Medicale

Volumn 36, Issue 1 I, 2007, Pages 50-56

  Verger, Pierre ^a,b   Clavaud, Henri ^c   Bidaud, Stéphanie ^a   Paraponaris, Alain ^b   Sauze, Laurent ^c  

^a OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^b INSERM   (France)

^c Caisse médicale régionale de Provence ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; PSYCHOTROPIC AGENT; ANTIDEPRESSANT AGENT;

ARTICLE; CASE CONTROL STUDY; CHRONIC DISEASE; CHRONIC PAIN; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISABILITY; DISTRESS SYNDROME; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MORBIDITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRESCRIPTION; RADIODIAGNOSIS; RADIOGRAPHY; REIMBURSEMENT; RISK ASSESSMENT; RURAL AREA; TIME SERIES ANALYSIS; URBAN AREA; ADOLESCENT; ADULT; AGED; DRUG UTILIZATION; FEMALE; FRANCE; MALE; MIDDLE AGED; SOMATOSENSORY DISORDER; STATISTICAL MODEL; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; ANALGESICS; ANTI-INFLAMMATORY AGENTS; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; DRUG UTILIZATION; FEMALE; FRANCE; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; LOGISTIC MODELS; MALE; MENTAL DISORDERS; MIDDLE AGED; RADIOGRAPHY; SOMATOSENSORY DISORDERS;

EID: 33947495299     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2006.07.004     Document Type: Article

References (31)

1. Agence du médicament. Étude de la prescription et de la consommation des antidépresseurs en ambulatoire. Paris : Agence du médicament, Direction des études et de l'information pharmaco-économiques, 1998.
2. Olie J.P., Elomari F., Spadone C., and Lepine J.P. Résultats d'une enquête sur l'usage des antidépresseurs en population générale française. Encephale 28 (2002) 411-417
3. Zarifian E. Mission générale concernant la prescription et l'utilisation des médicaments psychotropes en France (1996), Odile Jacob, Paris
4. Adeli. http://www.ameli.fr/244/DOC/2333/article.html (Medicam 2003-2004).
5. Agence Nationale pour le Développement de l'Evaluation Médicale. Recommandations et références médicales. Médicaments antidépresseurs. Concours Med 42 (1996) 4-15
6. Kessler D., Lloyd K., Lewis G., and Gray D.P. Cross sectional study of symptom attribution and recognition of depression and anxiety in primary care. BMJ 318 (1999) 436-439
7. Le Pape A., and Lecomte T. Prévalence et prise en charge médicale de la dépression en France 1996-1997 (1999), CREDES, Paris
8. Lecrubier Y., Boyer P., Lepine J.P., and Weiller E. Results from the Paris center. In: Ustün T.B., and Sartorius N. (Eds). Mental illness in general health care (1995), John Wiley & Sons, Chichester 211-225
9. Steer R.A., Cavalieri T.A., Leonard D.M., and Beck A.T. Use of the Beck Depression Inventory for Primary Care to screen for major depression disorders. Gen Hosp Psychiatry 21 (1999) 106-111
10. Scott J., Jennings T., Standart S., Ward R., and Goldberg D. The impact of training in problem-based interviewing on the detection and management of psychological problems presenting in primary care. Br J Gen Pract 49 (1999) 441-445
11. Weich S., Lewis G., Donmall R., and Mann A. Somatic presentation of psychiatric morbidity in general practice. Br J Gen Pract 45 (1995) 143-147
12. Von Korff M., Shapiro S., Burke J.D., Teitlebaum M., Skinner E.A., German P., et al. Anxiety and depression in a primary care clinic. Comparison of Diagnostic Interview Schedule, General Health Questionnaire, and practitioner assessments. Arch Gen Psychiatry 44 (1987) 152-156
13. Allilaire J.F. Comment-définit-on en 1996 les temps évolutifs de la dépression?. In: Lempérière T. (Ed). Aspects évolutifs de la dépression (1996), Acanthe, Masson, Paris 37-49
14. Le Goff P. La fibromyalgie est-elle une maladie du muscle?. Rev Rhum 73 (2006) 418-421
15. Rao S.G., and Bennett R.M. Pharmacological therapies in fibromyalgia. Best Pract Res Clin Rheumatol. 17 (2003) 611-627
16. Clauw D.J., and Crofford L.J. Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol. 17 (2003) 685-701
17. Dumolard A., and Juvin R. Fibromyalgie : aspects médico-sociaux. Rev Rhum 70 (2003) 310-313
18. Cathebras P., Mosnier C., Levy M., Bouchou K., and Rousset H. Dépistage de la dépression chez les patients hospitalisés en médecine. Comparaison de deux échelles d'autoévaluation et du jugement des cliniciens à un questionnaire structuré. Encephale 20 (1994) 311-317
19. Floyd B.J. Problems in accurate medical diagnosis of depression in female patients. Soc Sci Med 44 (1997) 403-412
20. Katon W.J. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 54 (2003) 216-226
21. Arnow B.A., Hunkeler E.M., Blasey C.M., Lee J., Constantino M.J., Fireman B., et al. Comorbid depression, chronic pain, and disability in primary care. Psychosom Med 68 (2006) 262-268
22. Dersh J., Polatin P.B., and Gatchel R.J. Chronic pain and psychopathology: research findings and theoretical considerations. Psychosom Med 64 (2002) 773-786
23. Currie S.R., and Wang J. More data on major depression as an antecedent risk factor for first onset of chronic back pain. Psychol Med 35 (2005) 1275-1282
24. Gasquet I., Bloch J., Cazeneuve B., Perrin E., and Bouhassira M. Déterminants de l'observance thérapeutique des antidépresseurs. Encephale 27 (2001) 83-91
25. Lawrenson R.A., Tyrer F., Newson R.B., and Farmer R.D. The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. J Affect Disord 59 (2000) 149-157
26. Tai-Seale M., Croghan T.W., and Obenchain R. Determinants of antidepressant treatment compliance: implications for policy. Med Care Res Rev 57 (2000) 491-512
27. Brown C., Battista D.R., Bruehlman R., Sereika S.S., Thase M.E., and Dunbar-Jacob J. Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence. Med Care 43 (2005) 1203-1207
28. Lepine J.P., Gastpar M., Mendlewicz J., and Tylee A. Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int Clin Psychopharmacol 12 (1997) 19-29
29. Linden M., Lecrubier Y., Bellantuono C., Benkert O., Kisely S., and Simon G. The prescribing of psychotropic drugs by primary care physicians: an international collaborative study. J Clin Psychopharmacol 19 (1999) 132-140
30. Furedi J., Rozsa S., Zambori J., and Szadoczky E. The role of symptoms in the recognition of mental health disorders in primary care. Psychosomatics 44 (2003) 402-406
31. Tiemens B.G., Von Korff M., and Lin E.H.B. Diagnosis of depression by primary care physicians versus a structured diagnostic interview. Gen Hosp Psychiatry 21 (1999) 86-96